Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg: Self-report versus serological evidence

Journal of Epidemiology and Community Health

Volumn 66, Issue 1, 2012, Pages 64-68

  Origer, Alain ^a,b   Schmit, Jean Claude ^b  

^a European Monitoring Centre on Drugs and Drug Addiction Focal point   (Luxembourg)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; DISEASE PREVALENCE; DRUG USER; HEALTH SURVEY; HEPATITIS; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; QUESTIONNAIRE SURVEY;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUXEMBOURG; MALE; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; QUESTIONNAIRE; RISK; SELF REPORT; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ADOLESCENT; ADULT; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; LUXEMBOURG; MALE; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; PREVALENCE; QUESTIONNAIRES; SELF REPORT; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

BELGIUM; LUXEMBOURG [BELGIUM];

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84855983680     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2009.101378     Document Type: Article

References (26)

1. Sloboda Z. Drug abuse epidemiology: an overview. Bull Narcotics 2002;LIV:1-13.
2. Latkin CA, Vlahov D. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction 1998;93:1191-7.
3. Langendam MW, Van Haastrecht HJ, Van Ameijden EJ. The validity of drug users' self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities. Int J Epidemiol 1999;28:514-20.
4. Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr 1997;167:17-36.
5. Strauss SM, Rindskopf DM, Seren S, et al. Concurrence of drug users' self-report of current HIV status and serotest results. J Acquir Immune Defic Syndr 2001;27:301-7.
6. EMCDDA Focal point Luxembourg-CRP-Santé. National report 2005 on the state of the drug phenomenon in the Grand Duchy of Luxembourg. Luxembourg: EMCDDA Focal point Luxembourg-CRP-Santé, 2006:117-25.
7. Fisher DG, Kuhrt-Hunstiger TI, Orr S, et al. Hepatitis B validity of drug users' selfreport. Psychol Addict Behav 1999;13:33-8.
8. Topp L, Day C, Dore GJ, et al. Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a review. Drug Alcohol Rev 2009;28:669-75.
9. Kleyn J, Schwebke J, Holmes KK. The validity of injecting drug users' self-reports about sexually transmitted diseases: a comparison of survey and serological data. Addiction 1993;88:673-80.
10. Crofts N, Nigro L, Oman K, et al. Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction 1997;92:999-1005.
11. Hagan H, Campbell J, Thiede H, et al. Self-reported hepatitis C virus antibody status and risk behaviour in young injectors. Public Health Rep 2006;121:710-19.
12. Weaver MF, Cropsey KL, Fox SA. HCV prevalence in methadone maintenance: selfreport versus serum test. Am J Health Behav 2005;29:387-94.
13. Stein MD, Maksad J, Clarke J. Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend 2001;61:211-15.
14. Thornton L, Barry J, Long J, et al. Comparison between selfreported hepatitis B, hepatitis C, and HIV antibody status and oral fluid assay results in Irish prisoners. Communicab Dis Public Health 2000;3:253-5.
15. Best D, Noble A, Finch E, et al. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. BMJ 1999;319:290-1.
16. Lo Re V, Frank I, Gross R, et al. Self reported hepatitis B and C virus infections had low sensitivity among HIV infected patients. J Clin Epidemiol 2007;60:294-9.
17. Schlicting EG, Johnson ME, Brems C, et al. Validity of injecting drug users' self report of hepatitis A, B, and C. Clin Lab Sci 2003;16:99.
18. Kuo I, Mudrick DW, Strathdee SA, et al. Poor validity of self reported hepatitis B virus infection and vaccination status among young drug users. Clin Infect Dis 2004;38:587-90.
19. De la Fuente L, Toro C, Brugal M, et al. Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy 'don't ask, draw a blood sample, vaccinate and try to schedule another visit'. J Clin Virol 2007;38:87-90.
20. Magnani R, Sabin K, Saidel T, et al. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 2005;19(Suppl 2):67-72.
21. MacKellar DA, Gallagher KM, Finlayson T, et al. Behaviors of men who have sex with men - a national application of venue-based, time-space sampling. Public Health Rep 2007;122(Suppl 1):39-47.
22. Lemp GF, Hirozawa AM, Givertz D, et al. Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men: the San Francisco/Berkeley Young Men's Survey. JAMA 1994;272:449-54.
23. Taylor A, Goldberg D, Hutchinson S, et al. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect 2000;40:176-83.
24. Haw S, Frischer M, Donoghoe M, et al. The importance of multisite sampling in determining the prevalence of HIV among drug injectors in Glasgow and London. AIDS 1992;6:517-18.
25. Donoghoe M, Rhodes T, Hunter G, et al. HIV testing and unreported HIV positivity among injecting drug users in London. AIDS 1993;7:1105-11.
26. Dunn J, Ferri CP, Laranjeira R. Does multisite sampling improve patient heterogeneity in drug misuse research? Drug Alcohol Depend 2001;63:79-85.